Mrs In Um

Research Fellow

Researcher profile

Email

ihu@st-andrews.ac.uk

Selected publications

• Evaluation of the dual mTOR/PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft models

  Langdon, S. P., Kay, C., Um, I. H., Muir, M., Sellar, G., Kan, J., Gourley, C. & Harrison, D. J., 10 Dec 2019, In : Scientific Reports. 9, 9 p., 18742.

  Research output: Contribution to journal ? Article

• Genome-scale CRISPR/Cas9 screen determines factors modulating sensitivity to ProTide NUC-1031

  Sarr, A., Bré, J., Um, I. H., Chan, T. H., Mullen, P., Harrison, D. J. & Reynolds, P. A., 21 May 2019, In : Scientific Reports. 9, 13 p., 7643.

  Research output: Contribution to journal ? Article

• Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models

  Koussounadis, A., Langdon, S., Um, I. H., Kay, C., Francis, K., Harrison, D. J. & Smith, V. A., 10 Mar 2016, In : BMC Cancer. 16, 13 p., 205.

  Research output: Contribution to journal ? Article

• Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models

  Ward, C., Meehan, J., Mullen, P., Supuran, C., Dixon, J. M., Thomas, J. S., Winum, J-Y., Lambin, P., Dubois, L., Pavathaneni, N-K., Jarman, E. J., Renshaw, L., Um, I. H., Kay, C., Harrison, D. J., Kunkler, I. H. & Langdon, S. P., 2015, In : Oncotarget. 6, 28, p. 24865-24870 15 p.

  Research output: Contribution to journal ? Article

• Multi-scale genomic, transcriptomic and proteomic analysis of colorectal cancer cell lines to identify novel biomarkers

  Briffa, R., Um, I. H., Faratian, D., Zhou, Y., Turnbull, A. K., Langdon, S. P. & Harrison, D. J., 17 Dec 2015, In : PLoS One. 10, 12, 29 p., e0144708.

  Research output: Contribution to journal ? Article

• Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system

  Koussounadis, A., Langdon, S., Um, I. H., Harrison, D. J. & Smith, V. A., 8 Jun 2015, In : Scientific Reports. 5, 9 p., 10775.

  Research output: Contribution to journal ? Article

• The role of HDAC2 in chromatin remodelling and response to chemotherapy in ovarian cancer

  Huang, R., Langdon, S. P., Tse, M., Mullen, P., Um, I. H., Faratian, D. & Harrison, D. J., 14 Dec 2015, In : Oncotarget. 7, 4, p. 4695-4711 17 p.

  Research output: Contribution to journal ? Article

• Characterisation of phosphorylated checkpoint kinase 1 as a poor prognostic biomarker in serous ovarian cancer

  Francis, K. E., Mullen, P., Um, I., Kay, C., Harrison, D. J. & Langdon, S. P., Sep 2013, In : Journal of Pathology. 231, p. 46 1 p.

  Research output: Contribution to journal ? Abstract

• The use of aromatase inhibitors in ovarian cancer and identification of responsive tumors: Aromatase inhibitors: Types, Mode of Action and Indications

  Langdon, S., Faratian, D., Gourley, C., Harrison, D., Um, I. H. & Smyth, J., 2009, Aromatase inhibitors: Types, Mode of Action and Indications. Nova Science Pub Incorporated, p. 163-174 12 p. (Cancer Etiology, Diagnosis and Treatment Series).

  Research output: Chapter in Book/Report/Conference proceeding ? Chapter

See more publications